New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
16:16 EDTAIS
theflyonthewall.com: Antares Pharma reports Q3 EPS (4c) vs. consensus of (4c)
Reports Q3 revenue $2.04M vs. consensus of $1.89M. :theflyonthewall.com



News For AIS From The Last 14 Days
Check below for free stories on AIS the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 2, 2010
11:02 EDTAIS
theflyonthewall.com: Antares says partner Teva introduced support resources for Tjet device
Antares Pharma (AIS) announced that Teva USA (TEVA) has introduced new patient support resources for the Tjet device and TEV-TROPIN. Antares licensed its novel delivery device to Teva, branded as Tjet for delivering TEV-TROPIN brand human growth hormone to children who have growth failure due to inadequate secretion of normal endogenous growth hormone. :theflyonthewall.com